scholarly journals Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes

2016 ◽  
Vol 9 (22) ◽  
pp. 2267-2276 ◽  
Author(s):  
Laurent Bonello ◽  
Marc Laine ◽  
Etienne Puymirat ◽  
Gilles Lemesle ◽  
Franck Thuny ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Acute Coronary Syndromes ◽  
Invasive Strategy ◽  
St Segment Elevation ◽  
St Segment ◽  
Coronary Syndromes

scholarly journals DETERMINANTS AND APPROPRIATENESS OF DECISION FOR INVASIVE STRATEGY IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES

2015 ◽  
Vol 65 (10) ◽  
pp. A123
Author(s):  
Luis Correia ◽  
Guilherme Garcia ◽  
Manuela Carvalhal ◽  
Felipe Kalil ◽  
Felipe Ferreira ◽  
...  
Keyword(s):  
Acute Coronary Syndromes ◽  
Invasive Strategy ◽  
St Segment Elevation ◽  
St Segment ◽  
Coronary Syndromes

Non-ST-segment elevation acute coronary syndromes

2021 ◽  
pp. 531-548
Author(s):  
Héctor Bueno ◽  
José A Barrabés
Keyword(s):  
Acute Coronary Syndromes ◽  
Coronary Thrombosis ◽  
Coronary Revascularization ◽  
Bypass Graft ◽  
Myocardial Necrosis ◽  
Invasive Strategy ◽  
St Segment Elevation ◽  
St Segment ◽  
Coronary Syndromes ◽  
High Event

Non-ST-segment elevation acute coronary syndromes are potentially life-threatening disorders, usually caused by acute coronary thrombosis and subsequent myocardial ischaemia, presenting without persistent ST-segment elevation in the initial electrocardiogram. According to the occurrence of myocardial necrosis, non-ST-segment elevation acute coronary syndromes are divided into non-ST-segment myocardial infarction or unstable angina. The management of non-ST-segment elevation acute coronary syndromes requires an early diagnosis and risk stratification, urgent hospitalization, monitoring, and medical treatment, including antithrombotic therapy with dual antiplatelet therapy (aspirin plus one P2Y12 inhibitor) and parenteral anticoagulation, anti-ischaemic treatment, and preventative therapies. After the initial medical therapy is established, an invasive strategy, consisting of coronary angiography with coronary revascularization (either percutaneous coronary intervention or coronary bypass graft surgery), as appropriate, should be decided. The timing of the invasive strategy should be adjusted according to the patient's risk. Given the high event rate of patients with non-ST-segment elevation acute coronary syndromes after hospital discharge, an aggressive long-term preventative therapy should be put in place to improve prognosis.

scholarly journals Serum Amyloid A is a Better Predictor of Clinical Outcomes than C-Reactive Protein in Non-ST-Segment Elevation Acute Coronary Syndromes

2007 ◽  
Vol 71 (2) ◽  
pp. 186-190 ◽  
Author(s):  
Masami Kosuge ◽  
Toshiaki Ebina ◽  
Toshiyuki Ishikawa ◽  
Kiyoshi Hibi ◽  
Kengo Tsukahara ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Acute Coronary Syndromes ◽  
Serum Amyloid A ◽  
Serum Amyloid ◽  
C Reactive Protein ◽  
St Segment Elevation ◽  
Reactive Protein ◽  
Amyloid A ◽  
St Segment ◽  
Coronary Syndromes

Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes

2013 ◽  
Vol 158 (4) ◽  
pp. 261 ◽  
Author(s):  
Eliano P. Navarese ◽  
Paul A. Gurbel ◽  
Felicita Andreotti ◽  
Udaya Tantry ◽  
Young-Hoon Jeong ◽  
...  
Keyword(s):  
Acute Coronary Syndromes ◽  
Optimal Timing ◽  
Invasive Strategy ◽  
St Segment Elevation ◽  
St Segment ◽  
Coronary Syndromes
Sign in / Sign up

Export Citation Format

Share Document